Pre-eclampsia is a life-threatening disease of pregnancy unique to humans and a leading
cause of maternal and neonatal morbidity and mortality. Women who survive pre-eclampsia …

Preeclampsia Preeclampsia complicates 2 to 4% of all pregnancies and accounts for about
46,000 maternal deaths and 500,000 fetal or newborn deaths each year. Antihypertensive …

Importance Pregnancy hypertension results in adverse cardiac remodeling and higher
incidence of hypertension and cardiovascular diseases in later life. Objective To evaluate …

Objective To test the feasibility of a randomised trial of home blood pressure monitoring
paired with a remote lifestyle intervention (Heart Health 4 New Moms) versus home blood …

Background Chronic hypertension (CHT) is the main risk factor for cardiovascular diseases
in women with a history of hypertensive disorders of pregnancy (HDP). Objectives This study …

There is widespread acceptance of the increased prevalence of cardiovascular diseases
occurring within 1 to 2 decades in women following a preeclamptic pregnancy. More recent …

BACKGROUND: Hypertensive pregnancy disorders are associated with adverse cardiac
remodeling, which can fail to reverse in the postpartum period in some women. The …

Aims Pre-eclampsia increases women's lifetime risk of cardiovascular disease (CVD). Little
is known about the trajectory of CVD after pre-eclampsia, limiting the usefulness of this …

Hypertensive disorders of pregnancy (HDP) complicate approximately 10% of pregnancies.
In addition to multiorgan manifestations related to endothelial dysfunction, HDP confers an …

Development of a comprehensive postpartum care plan with careful consideration of each
patient's risk profile and access to resources is critical to improve maternal morbidity and …